Evidence map›Paper›PMID 35841703›Full record

ArticlePsychiatry research2022

The effect of a real-world intervention for smoking cessation in Adults with and without comorbid psychiatric and substance use disorders: A one-year follow-up study.

Danielle Ruiz Lima, Bruna Beatriz Sales Guimaraes-Pereira, Zachary L Mannes, Carlos Felipe Cavalcanti Carvalho, Aline Rodrigues Loreto, Lucas Carvalho Davanso, Fernanda Piotto Frallonardo, Flavia Ismael, Arthur Guerra de Andrade, Joao Mauricio Castaldelli-Maia

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Psychiatry research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Danielle Ruiz LimaGrupo Interdisciplinar de Estudos de Alcool e outras Drogas (GREA), Instituto de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR. Electronic address: elleruiz@hotmail.com.
Bruna Beatriz Sales Guimaraes-PereiraDepartment of Neuroscience, Medical School, ABC Foundation, Santo André - SP, 09060-870, Santo Andre, SP, BR.
Zachary L MannesDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, U.S., 10032.
Carlos Felipe Cavalcanti CarvalhoABC Center for Mental Health Studies, Santo André - SP, 09060-870, Santo Andre, SP, Brazil.
Aline Rodrigues LoretoABC Center for Mental Health Studies, Santo André - SP, 09060-870, Santo Andre, SP, Brazil.
Lucas Carvalho DavansoDepartment of Neuroscience, Medical School, ABC Foundation, Santo André - SP, 09060-870, Santo Andre, SP, BR.
Fernanda Piotto FrallonardoABC Center for Mental Health Studies, Santo André - SP, 09060-870, Santo Andre, SP, Brazil; Universidade Municipal de São Caetano do Sul - Campus Centro, São Caetano do Sul, Sao Paulo, 09521-160, Brazil.
Flavia IsmaelABC Center for Mental Health Studies, Santo André - SP, 09060-870, Santo Andre, SP, Brazil; Universidade Municipal de São Caetano do Sul - Campus Centro, São Caetano do Sul, Sao Paulo, 09521-160, Brazil.
Arthur Guerra de AndradeGrupo Interdisciplinar de Estudos de Alcool e outras Drogas (GREA), Instituto de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR; Department of Neuroscience, Medical School, ABC Foundation, Santo André - SP, 09060-870, Santo Andre, SP, BR; ABC Center for Mental Health Studies, Santo André - SP, 09060-870, Santo Andre, SP, Brazil.
Joao Mauricio Castaldelli-MaiaGrupo Interdisciplinar de Estudos de Alcool e outras Drogas (GREA), Instituto de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR; Department of Neuroscience, Medical School, ABC Foundation, Santo André - SP, 09060-870, Santo Andre, SP, BR; ABC Center for Mental Health Studies, Santo André - SP, 09060-870, Santo Andre, SP, Brazil; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, U.S., 10032.
Universidade de São Paulo · BRFaculdade de Medicina do ABC · BRFundação do ABC · BRUniversidade Municipal de São Caetano do Sul · BRColumbia University · US

Funding

Substance Abuse Epidemiology Training Program (SAETP) at Columbia UniversityT32DA031099 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DEBORAH S HASIN, Silvia Saboia Martins · 2012 to 2026
$6.1M
NIDA NIH HHS T32 DA031099
6 · The paper itself

Abstract

This study evaluated short-term abstinence and prolonged abstinence following a real-world intervention for smoking cessation in a sample of 1,213 adults with nicotine dependence only (ND), nicotine dependence and past history of another substance use disorder (ND-SUD), nicotine dependence and a non-substance use mental health disorder (ND-MD), or nicotine dependence and comorbid substance use disorder and mental health disorder (ND-SUMD). Participants received six sessions of group Cognitive Behavioral Therapy (CBT) and pharmacotherapy. Abstinence was assessed following completion of treatment and at 12-month follow-up. Logistic regression and survival analyses were performed. Participants who were lost to follow-up were included as censored and baseline differences were used as covariates in multivariate analyses. Rates of short-term abstinence and prolonged abstinence were significantly different between ND and ND-SUMD (20.9% versus 36.5%; 14.9% versus 22.4%, respectively). Among participants with follow-up, 37.7% were abstinent at 12-month. Diagnostic group was not associated with abstinence at 12-month follow-up after adjusting for nicotine dependence severity, which was associated with lower likelihood of abstinence (HR=1.11;95%CI:1.03-1.19). CBT plus pharmacotherapy had a positive effect on smoking cessation among the participants in this study. Special attention should be given to adults with more severe nicotine dependence and comorbid psychiatric and substance use disorders.

Indexed as

Smoking CessationSubstance-Related DisordersTobacco Use DisorderAdultFollow-Up StudiesHumansTobacco Use Cessation DevicesPsychiatric disordersSmoking cessationSubstance use disordersTobaccoTreatment outcome

Identifiers

PMID35841703
PMCPMC11055494
OpenAlexW4284972383

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.